Chapter 48: Antimalarial, Antiprotozoal & Anthelmintic Drugs

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

Today we're tackling some pretty specialized stuff.

Chapter 48 from the Canadian Pharmacology Practice Text.

It's all about antimalarial, antiprotozoal, and anthelmintic drugs.

Yeah, our goal here is to really break down these key drug classes.

We want to understand, you know, how they work, their mechanisms, and maybe most importantly, nail down those crucial nursing considerations for keeping patients safe.

It's niche but globally significant.

It really is essential stuff.

These drugs fight some incredibly complex bugs, basically.

We're looking at two main groups, protozoa.

Those are the single -celled ones like

causing malaria and helminths, which are, well, parasitic worms, much more complex.

And while, thankfully, good sanitation limits them here in Canada compared to globally, they're still very relevant.

Think travel, immigration, and especially people who are immunocompromised.

The global burden is just immense, billions affected.

Billions.

Wow.

Okay, so let's maybe define a few key terms first just to make sure we're all on the same page.

Malaria, obviously, caused by plasmodium.

Anti -protozoal drugs against protozoa.

And anthelmintic drugs against those worms, the helminths.

Exactly.

Simple definitions for some complex enemies.

Let's start with the biggest one then, malaria.

The stats in the source are just, well, staggering.

Something like 250 million infections a year and over a million deaths worldwide, mostly kids.

That's right.

And the transmission vector is very specific.

It's the bite of an infected female Anopheles mosquito.

The source material has a good illustration of this, emphasizing the female mosquito part.

Okay, so the mosquito delivers the punch, but the real villain is the plasmodium parasite inside.

Precisely.

And its life cycle is, frankly, mind -bendingly complex.

Understanding this cycle, which the chapter illustrates quite well, is absolutely critical for treatment.

You've basically got two connected cycles.

One happens in the mosquito, that's the sexual cycle.

The other happens in us, the human host, that's the asexual cycle.

And the human cycle has two parts.

Yep.

First is the exerathoracitic phase.

Think outside the red blood cells.

This is happening quietly in the liver.

The parasite's maturing, but the person doesn't feel sick yet.

It's kind of a silent invasion.

Okay, silent phase in the liver.

Then what?

Then comes the erythrocytic phase.

Inside the red blood cells, the parasites burst out of the liver, invade red blood cells, multiply like crazy, and then rupture them.

This is when the classic malaria symptoms hit.

Ah, the malaria paroxysm.

The book describes it vividly.

It starts with just intense chills,

shaking rigor, they call it.

Right, uncontrollable shivering.

Followed by this raging fever, up to 40 Celsius sometimes, and then just pouring sweat, diaphoresis.

And the worst part is it repeats every 48 to 72 hours, like clockwork.

It's a brutal cycle.

Now, before you even think about treating that, you absolutely confirm the diagnosis.

That means a blood smear, looking for the parasite.

Okay, diagnosis first,

then treatment.

Then treatment, and it has to be immediate.

But it's not one size fits all.

The choice of drug depends on three things.

Which plasmodium species it is, how sick the patient actually is, and critically, where they likely got infected.

Because that tells you about potential drug resistance.

Right, drug resistance is a huge factor.

Yeah.

Okay, so knowing that complex life cycle.

Yeah.

How do the drugs actually target it?

Where do they hit?

Good question.

Let's start with maybe the most familiar names, the four aminokinolins.

This group includes chloroquine and hydroxychloroquine.

Okay, how do they work?

Their mechanism is quite neat, actually.

They stop the parasite from making its own DNA and RNA, but maybe, more importantly, they get inside the parasite's little food sacks, its vacuoles, and they raise the pH in there.

Raise the pH.

So they make it less acidic.

Exactly.

And the parasite needs that acidic environment to break down hemoglobin, its food source from our red blood cells.

Raising the pH messes that whole process up.

It essentially starves the parasite from the inside.

Clever.

But where in the cycle do they work?

Key point.

They work almost exclusively in the erythrocytic phase, the blood phase.

They're great at clearing the parasites, circulating in the blood, and stopping the symptoms.

But they don't touch the parasites hiding in the liver, that exerathoracitic phase.

So they manage the attack, but don't necessarily stop future attacks from the liver stash.

Pretty much.

For some plasmodium species, anyway.

Now, hydroxychloroquine is interesting.

It's not just an anti -malarial.

It also has significant anti -inflammatory effects.

Right.

That's why you see it used for things totally unrelated to malaria, like rheumatoid arthritis, RA, and lupus, SLE.

Exactly.

It's a real multi -tasker in the drug world.

Okay.

So four emitting quinolines hit the blood phase.

What about that tricky liver phase?

That's where primakine phosphate comes in.

It's an A -aminokinoline.

Different chemical structure, different job.

Primakine works by binding to and messing up the parasite's DNA.

And its target phase.

This is the crucial bit.

Primakine is one of the very few drugs effective during the exerathoracitic phase, the liver phase.

This makes it absolutely vital for achieving a true cure, especially for species like PVBACs that are famous for lying dormant in the liver for ages.

So primakine for the liver hideout.

Got it.

What about mefloquine?

It's used a lot for prevention, right?

Prophylaxis.

Yes.

Mefloquine is important for both prophylaxis and treating strains that are resistant to other drugs like chloroquine.

But it comes with a really serious warning flag.

Ah, the mental health side effects.

Absolutely.

It has significant central nervous system effects.

The source material is very clear.

You cannot use mefloquine in patients who have active depression or a history of serious mental health issues like psychosis or even generalized anxiety disorder.

It can trigger or worsen these conditions.

It's a major contraindication.

Okay.

Really important safety point there.

So that covers the big malaria drugs.

What about other protozoal infections?

Right.

Malaria gets the headlines, but there are other important ones.

Think amoebolisis, which causes severe diarrhea or dysentery.

Then there's gerardiasis.

That's the one often come beaver fever here in Canada, usually from contaminated water.

And trichomoniasis, which is a common sexually transmitted infection.

And the chapter also mentions pneumocystosis caused by pneumocystis gerovechiae.

That one's a bit odd, isn't it?

Because technically it's now classified as a fungus.

It is.

Yeah, that's a fairly recent reclassification.

But traditionally and clinically, it's often managed with drugs covered in this antiprotozoal section, like adovacone and pentamidine.

It's a major issue, especially as an opportunistic infection in people with HIV AIDS causing severe pneumonia, PJP.

Okay.

So for treating these non -malarial protozoa and even some bacteria, there's one drug that seems to pop up everywhere.

Metronidazole.

Phlogel.

Ah, Metronidazole, the workhorse.

It's incredibly versatile.

Its mechanism involves interfering with the pathogen's DNA, which leads to cell death.

And its spectrum is broad.

Very broad.

It hits protozoa like trichomonas, gerardia and temeba histolytica, but it's also a go -to drug for serious anaerobic bacterial infections.

Think intra -abdominal infections, certain types of C difficile associated diarrhea.

It's really widely used.

Which brings us to maybe the most critical patient safety warning in this whole chapter.

The source highlights it with a case study, a student drinking alcohol while on metronidazole.

Yes, the disulfiram -like reaction.

This is non -negotiable patient teaching.

If a patient drinks alcohol while taking metronidazole, they can get violently ill.

What happens exactly?

It's often called the

after the drug used to deter alcoholism.

You get intense flushing, headache, nausea, severe vomiting, sweating,

erasing heart tachycardia.

It's miserable and potentially dangerous.

And the reason is biochemical, right?

It stops the breakdown of alcohol.

Precisely.

Metronidazole blocks an enzyme needed to break down acetaldehyde, which is a toxic byproduct of alcohol metabolism.

Acetaldehyde builds up, causing the reaction.

So the rule is absolute.

No alcohol while taking metronidazole, and for at least 48 hours, some sources say 72 hours after the last dose.

Got it.

Zero alcohol.

What about pentaminin -icetand?

You mentioned it for PJP.

Right.

Pentaminin is usually reserved for more serious stuff, primarily that Pgerivace pneumonia, often in immunocompromised patients like those with advanced HIV.

The key thing to remember is how it's given, only parenterally, meaning IV or IM injections.

IV or IM.

Any issues with that?

IV is generally preferred.

IM injections can be problematic.

They can cause intense pain, tenderness, and even sterile abscesses at the injection site.

So you need to be cautious with IM administration and rotate sites carefully.

Okay, good to know.

Let's shift gears now to the third category.

Helminths.

Worms.

Worms, yes.

Tapeworms, flukes, roundworms.

Now, in Canada and other developed countries, good sanitation has massively reduced the incidents compared to, say, protozoal infections.

But they definitely still occur.

The most common one mentioned for Canada is Enterobiasis pinworm.

Pinworm.

Lots of school kids get that, right?

Exactly.

Highly contagious, especially in daycare or school settings.

Now, the absolute core principle for treating any helminthic infection is crucial.

Let me guess.

Drug specificity.

You got it.

The drug must be specific to the worm.

These aren't bacteria where you might use a broad -spectrum approach sometimes.

Worms are complex, multicellular animals.

A drug that kills a tapeworm might do nothing to a roundworm.

So you have to know exactly which worm you're fighting before you treat.

How do you find out?

Diagnosis is key.

It usually involves laboratory analysis identifying the specific ova, eggs, or larva in samples like feces, urine, sometimes blood or tissue biopsies, depending on the worm.

No guessing allowed.

Makes sense.

So let's look at a couple of the main anthelmintic drugs mentioned.

How about Proziquantel?

Bilgercide.

Proziquantel is primarily used for flukes and tapeworms.

Its mechanism is quite dramatic.

It basically messes with calcium movement across the worm's cell membranes.

Calcium.

What does that do to a worm?

It causes a massive influx of calcium, leading to intense muscle contractions, spasms, and paralysis in the worm.

They lose their grip literally if they're attached to the gut wall, get dislodged, and then the host's immune system can often clear them out.

Wow.

Any major warnings for Proziquantel?

Yes.

A very specific contraindication.

Ocular cysticercosis.

That's a tapeworm larva infection inside the eye.

Giving Proziquantel in that situation is dangerous because killing the larva inside the eye can cause irreversible damage and blindness.

So eye infections are a definite no -go.

Okay.

Avoiding eye infections.

What about the other common one, especially for pinworm?

Paranthal pamote.

I think the it's over the counter in Canada.

That's right.

Paranthal pamote, often sold as Combandrin, is available OTC here, mainly targeting pinworms and some other roundworms.

Its mechanism is different from Proziquantel.

It works at the worm's neuromuscular junction.

How so?

It blocks the action of acetylcholine, which is a key neurotransmitter for muscle contraction.

This causes the worm to become paralyzed.

It doesn't necessarily kill it directly, but a paralyzed worm can't maintain his position in the gut.

So it just gets flushed out?

Exactly.

Normal gut movement, peristalsis, just carries the paralyzed worm out with the feces.

It's a mechanical solution in a way.

Effective and relatively simple.

Okay.

That covers the main drug types.

Now let's tie this all back to nursing practice.

What are the absolute must -do assessments when dealing with any of these drugs?

Right.

The nursing process is critical.

Assessment starts with a really thorough history.

You need travel history, obviously, food preparation and source history, especially for things like mebiasis or GRD -ASIS.

And for elements like pinworm, you absolutely need to assess all household members because it spreads so easily.

Makes sense.

What about lab work?

Essential.

Baseline kidney and live -for -function tests are standard, as many of these drugs are processed by the liver or excreted by the kidneys.

But the big one, the one you absolutely cannot miss, particularly before giving primakine or sometimes other anti -malarials, is testing for G6PD deficiency.

Why is that so critical?

Because if a patient has this genetic deficiency, giving them a drug like primakine can trigger hemolytic anemia.

Their red blood cells basically start breaking apart.

It can be life -threatening.

So screening for G6PD deficiency beforehand is a mandatory safety check.

Okay.

G6PD test is a must for primakine.

What about monitoring specific organs?

Definitely.

Given the potential toxicities, you need baseline checks.

For the four -minute quinolines like chloroquine and especially with long -term use like in RA or lupus, you need baseline visual acuity testing and regular eye exams because of the risk of retinal damage.

Eyes for chloroquine.

Baseline hearing tests are recommended for patients starting primakine.

And you always need to monitor neurological status, look for dizziness, confusion, headache, especially with drugs like metronidazole or mefloquine.

Right.

So thorough assessment is key.

Now implementation, giving the meds and teaching the patient.

What are the big points?

Adherence is probably number one.

These treatments only work if taken correctly.

For administration, a practical tip.

Most oral anti -malarials and drugs like metronidazole or adovacone should be given with food or milk.

They can cause significant GI upset, nausea, vomiting, cramps, and food helps buffer that.

Good tip.

Take with food.

What else are you teaching?

You absolutely must stress taking the entire course of medication exactly as prescribed.

Even if the patient starts feeling better after a few days, which they often do, stopping early can lead to relapse, especially with malaria, and contributes to the huge problem of drug resistance.

Don't stop early, even if you feel better.

Got it.

Any special instructions for collecting samples like for the worm diagnosis?

Yes.

For stool specimens needed to find ova and parasites, the instructions are very specific.

The stool sample must not touch water, so no collecting from the toilet bowl, and it shouldn't be contaminated with urine or chemicals like disinfectants.

These things can destroy the eggs or larvae and give you a false, negative result.

Okay, keep the stool sample pure.

Any other teaching pearls?

Two more mentioned in the text.

Patients taking quinine sulfate need serious sun safety teaching hats, sunscreen, protective clothing because it causes significant photosensitivity, easy sunburn.

Quinine and sun don't mix.

And the last one.

Inform patients taking primakine that it might turn their urine dark, reddish -brown, or darker.

It's a harmless side effect caused by the drug metabolites, but if patients aren't warned, they might panic and think something is seriously wrong, like bleeding.

Forewarning prevents unnecessary anxiety.

Excellent practical tips.

Okay, let's try to wrap this up.

A quick recap.

Sure.

We've covered three big categories.

Malaria, other protozoal infections, and helminthic worm infections.

We saw how complex malaria is with its liver and blood phases, and how drugs like chloroquine target the blood while primakine hits the liver.

We looked at versatile drugs like metronidazole for various protozoa and bacteria, remembering that crucial alcohol interaction.

And for worms, the key was drug specificity, needing diagnosis first with drugs like proziquantel paralyzing flukes and pyrantal paralyzing pinworms.

Right.

And underlying all of it are those critical nursing points.

Detailed assessment, including travel and household contacts, vital lab checks like G6PD, organ monitoring for toxicity, and really emphasizing adherence and specific patient teaching points like taking meds with food, completing the course, and avoiding alcohol with metronidazole.

So what this really means for you, the listener, in practice, is that managing these infections isn't simple.

Success depends heavily on getting that assessment right, ensuring the patient takes the drug correctly, and being vigilant for those specific risks like the G6PD issue or that metronidazole alcohol reaction.

It definitely highlights the need for specialized knowledge,

which brings us to a final thought to leave you with, something to ponder.

Okay.

Given how much people travel now and the scary rise of drug resistant parasites, especially plasmodium, telsaparam, malaria, how do you think future drug development needs to shift?

Should the focus move more towards hitting those harder to reach stages, like really nailing that liver phase, maybe aiming for true eradication, rather than just managing the blood stage infection?

That's a great question.

Tackling that silent liver stage, the exericitic phase, is arguably the holy grail for malaria eradication.

If you can reliably clear that, you prevent relapse and potentially block transmission too.

That's likely where a lot of future research effort needs to go.

It's a much tougher target, pharmacologically speaking.

A tougher target, but maybe the key to turning the tide.

Definitely something to think about.

Absolutely.

Well, thank you for joining us on this deep dive into a really complex area of pharmacology.

We hope this breakdown was helpful.

Yes.

Thanks everyone for tuning in.

We appreciate you being part of the Last Minute Lecture family.